Molecular Endocrinology, Vol 6, 877-884, Copyright © 1992 by Endocrine Society

ARTICLES

Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line

PR Murphy, Y Sato and RS Knee
Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada.

Basic fibroblast growth factor (bFGF) is a broad spectrum mitogen for many cells of neuroectodermal origin, including glial cells. The human malignant glioblastoma cell line U87-MG expresses high steady state levels of the bFGF mRNA and contains abundant stores of biologically active bFGF protein. In the present study we have examined the contribution of endogenous bFGF to the autocrine growth of these cells. Using reverse transcription-polymerase chain reaction, U87-MG cells were shown to express the mRNAs for both bFGF and the bFGF receptor, confirming the existence of the basic requirements for an autocrine loop. Addition of 5 microM bFGF-specific antisense oligonucleotide to U87-MG cultures significantly inhibited the growth rate of these cells within 48 h and blocked proliferation beyond 2 days. The corresponding bFGF-specific sense oligonucleotide did not significantly inhibit cell proliferation over the course of these experiments. Similarly, antisense oligonucleotides significantly inhibited colony formation in soft agar, while the sense sequence was without effect. Western blotting with antihuman bFGF revealed that U87-MG cells synthesize three isoforms of bFGF, approximately 18, 23, and 25 kilodaltons (kDa) in size. The 23- and 25-kDa isoforms together comprise approximately 80% of the total cellular stores of bFGF. Antisense treatment for 4 days reduced the abundance of the 23- and 25-kDa isoforms by 64-74%, but had little effect on the 18-kDa isoform. The inhibitory effect of the antisense oligonucleotides on anchorage-dependent proliferation was reversed by the addition of recombinant 18-kDa human bFGF.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S.-C. Mei and R.-T. Wu The G-rich promoter and G-rich coding sequence of basic fibroblast growth factor are the targets of thalidomide in glioma Mol. Cancer Ther., August 1, 2008; 7(8): 2405 - 2414. [Abstract] [Full Text] [PDF]

				C. Barclay, A. W. Li, L. Geldenhuys, M. Baguma-Nibasheka, G. A. Porter, P. J. Veugelers, P. R. Murphy, and A. G. Casson Basic Fibroblast Growth Factor (FGF-2) Overexpression Is a Risk Factor for Esophageal Cancer Recurrence and Reduced Survival, which Is Ameliorated by Coexpression of the FGF-2 Antisense Gene Clin. Cancer Res., November 1, 2005; 11(21): 7683 - 7691. [Abstract] [Full Text] [PDF]

				A. Mihalich, M. Reina, S. Mangioni, E. Ponti, L. Alberti, P. Vigano, M. Vignali, and A. M. Di Blasio Different Basic Fibroblast Growth Factor and Fibroblast Growth Factor-Antisense Expression in Eutopic Endometrial Stromal Cells Derived from Women with and without Endometriosis J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2853 - 2859. [Abstract] [Full Text] [PDF]

				P. I. Meneses, L. E. Abrey, K. A. Hajjar, S. H. Gultekin, R. M. Duvoisin, K. I. Berns, and M. R. Rosenfeld Simplified Production of a Recombinant Human Angiostatin Derivative That Suppresses Intracerebral Glial Tumor Growth Clin. Cancer Res., November 1, 1999; 5(11): 3689 - 3694. [Abstract] [Full Text] [PDF]

				R. Knee, A. W. Li, and P. R. Murphy Characterization and tissue-specific expression of the rat basic fibroblast growth factor antisense mRNA and protein PNAS, May 13, 1997; 94(10): 4943 - 4947. [Abstract] [Full Text] [PDF]

				J. C. Fox and J. R. Shanley Antisense Inhibition of Basic Fibroblast Growth Factor Induces Apoptosis in Vascular Smooth Muscle Cells J. Biol. Chem., May 24, 1996; 271(21): 12578 - 12584. [Abstract] [Full Text] [PDF]